These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 36203151)

  • 1. Lipid metabolic features of T cells in the Tumor Microenvironment.
    Lou W; Gong C; Ye Z; Hu Y; Zhu M; Fang Z; Xu H
    Lipids Health Dis; 2022 Oct; 21(1):94. PubMed ID: 36203151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-programmed nutrient partitioning in the tumour microenvironment.
    Reinfeld BI; Madden MZ; Wolf MM; Chytil A; Bader JE; Patterson AR; Sugiura A; Cohen AS; Ali A; Do BT; Muir A; Lewis CA; Hongo RA; Young KL; Brown RE; Todd VM; Huffstater T; Abraham A; O'Neil RT; Wilson MH; Xin F; Tantawy MN; Merryman WD; Johnson RW; Williams CS; Mason EF; Mason FM; Beckermann KE; Vander Heiden MG; Manning HC; Rathmell JC; Rathmell WK
    Nature; 2021 May; 593(7858):282-288. PubMed ID: 33828302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy.
    Zhang M; Wei T; Zhang X; Guo D
    Front Immunol; 2022; 13():937406. PubMed ID: 36131916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.
    Nachef M; Ali AK; Almutairi SM; Lee SH
    Front Immunol; 2021; 12():624324. PubMed ID: 33953707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy.
    Lim AR; Rathmell WK; Rathmell JC
    Elife; 2020 May; 9():. PubMed ID: 32367803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Microenvironment: A Metabolic Player that Shapes the Immune Response.
    Cassim S; Pouyssegur J
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31881671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PA suppresses antitumor immunity of T cells by disturbing mitochondrial activity through Akt/mTOR-mediated Ca
    Sun S; Xu H; Zhao W; Li Q; Yuan Y; Zhang G; Li S; Wang B; Zhang W; Gao X; Zheng J; Zhang Q
    Cancer Lett; 2024 Jan; 581():216511. PubMed ID: 38013049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of metabolic reprogramming on the immune microenvironment in gastric cancer.
    Shang Z; Ma Z; Wu E; Chen X; Tuo B; Li T; Liu X
    Biomed Pharmacother; 2024 Jan; 170():116030. PubMed ID: 38128177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid Metabolism in Tumor-Infiltrating T Cells.
    He S; Cai T; Yuan J; Zheng X; Yang W
    Adv Exp Med Biol; 2021; 1316():149-167. PubMed ID: 33740249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time.
    Pasello G; Zago G; Lunardi F; Urso L; Kern I; Vlacic G; Grosso F; Mencoboni M; Ceresoli GL; Schiavon M; Pezzuto F; Pavan A; Vuljan SE; Del Bianco P; Conte P; Rea F; Calabrese F
    Ann Oncol; 2018 May; 29(5):1258-1265. PubMed ID: 29514216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting.
    Yu YR; Ho PC
    Clin Exp Immunol; 2019 Aug; 197(2):153-160. PubMed ID: 30873592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity.
    Yan Y; Huang L; Liu Y; Yi M; Chu Q; Jiao D; Wu K
    J Hematol Oncol; 2022 Aug; 15(1):104. PubMed ID: 35948909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty Acid Metabolism in Ovarian Cancer: Therapeutic Implications.
    Yoon H; Lee S
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic programming and immune suppression in the tumor microenvironment.
    Arner EN; Rathmell JC
    Cancer Cell; 2023 Mar; 41(3):421-433. PubMed ID: 36801000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors.
    Wang H; Franco F; Tsui YC; Xie X; Trefny MP; Zappasodi R; Mohmood SR; Fernández-García J; Tsai CH; Schulze I; Picard F; Meylan E; Silverstein R; Goldberg I; Fendt SM; Wolchok JD; Merghoub T; Jandus C; Zippelius A; Ho PC
    Nat Immunol; 2020 Mar; 21(3):298-308. PubMed ID: 32066953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview: Lipid Metabolism in the Tumor Microenvironment.
    Ma K; Zhang L
    Adv Exp Med Biol; 2021; 1316():41-47. PubMed ID: 33740242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipids in the tumor microenvironment: immune modulation and metastasis.
    Pascual G; Benitah SA
    Front Oncol; 2024; 14():1435480. PubMed ID: 39391242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
    Abe S; Nagata H; Crosby EJ; Inoue Y; Kaneko K; Liu CX; Yang X; Wang T; Acharya CR; Agarwal P; Snyder J; Gwin W; Morse MA; Zhong P; Lyerly HK; Osada T
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of FABP5 in T Cell Lipid Metabolism and Function in the Tumor Microenvironment.
    Jin R; Hao J; Yu J; Wang P; Sauter ER; Li B
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.